HLB Life Science Co., Ltd. (067630.KQ)
KRW 9780.0
(-1.81%)
KRW 9780.0
(-1.81%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 149.8 Billion KRW | 28.6% |
| 2022 | 116.49 Billion KRW | 537.41% |
| 2021 | -26.63 Billion KRW | -3.37% |
| 2020 | -25.76 Billion KRW | -3.92% |
| 2019 | -24.79 Billion KRW | -132.27% |
| 2018 | 76.83 Billion KRW | 3856.67% |
| 2017 | -2.04 Billion KRW | -113.41% |
| 2016 | 15.25 Billion KRW | 250.22% |
| 2015 | -10.15 Billion KRW | -220.96% |
| 2014 | 8.39 Billion KRW | -51.35% |
| 2013 | 17.25 Billion KRW | 2408.58% |
| 2012 | -747.47 Million KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 117.02 Billion KRW | -21.88% |
| 2024 Q2 | 71.45 Billion KRW | -38.94% |
| 2023 Q1 | 121.68 Billion KRW | 4.45% |
| 2023 Q3 | 144.24 Billion KRW | 16.63% |
| 2023 Q4 | 149.8 Billion KRW | 3.86% |
| 2023 FY | 149.8 Billion KRW | 28.6% |
| 2023 Q2 | 123.67 Billion KRW | 1.64% |
| 2022 Q3 | 91.2 Billion KRW | 290.28% |
| 2022 FY | 116.49 Billion KRW | 537.41% |
| 2022 Q4 | 116.49 Billion KRW | 27.73% |
| 2022 Q2 | -47.93 Billion KRW | -78.64% |
| 2022 Q1 | -26.83 Billion KRW | -0.75% |
| 2021 Q4 | -26.63 Billion KRW | -11.89% |
| 2021 Q3 | -23.8 Billion KRW | 43.48% |
| 2021 FY | -26.63 Billion KRW | -3.37% |
| 2021 Q1 | -34.24 Billion KRW | -31.0% |
| 2021 Q2 | -42.11 Billion KRW | -22.96% |
| 2020 Q3 | 1.91 Billion KRW | 119.37% |
| 2020 Q4 | -26.14 Billion KRW | -1468.48% |
| 2020 Q1 | -13.14 Billion KRW | 48.42% |
| 2020 Q2 | -9.86 Billion KRW | 25.0% |
| 2020 FY | -25.76 Billion KRW | -3.92% |
| 2019 Q1 | 8.4 Billion KRW | -89.06% |
| 2019 FY | -24.79 Billion KRW | -132.27% |
| 2019 Q4 | -25.49 Billion KRW | -365.97% |
| 2019 Q3 | -5.47 Billion KRW | 71.89% |
| 2019 Q2 | -19.46 Billion KRW | -331.57% |
| 2018 Q4 | 76.83 Billion KRW | 10.42% |
| 2018 FY | 76.83 Billion KRW | 3856.67% |
| 2018 Q3 | 69.58 Billion KRW | 10.08% |
| 2018 Q2 | 63.21 Billion KRW | -3.26% |
| 2018 Q1 | 65.34 Billion KRW | 3295.03% |
| 2017 Q1 | 23.93 Billion KRW | 25.9% |
| 2017 Q2 | 20.18 Billion KRW | -15.64% |
| 2017 Q3 | 15.51 Billion KRW | -23.15% |
| 2017 Q4 | -2.04 Billion KRW | -113.18% |
| 2017 FY | -2.04 Billion KRW | -113.41% |
| 2016 Q4 | 19 Billion KRW | -11.65% |
| 2016 FY | 15.25 Billion KRW | 250.22% |
| 2016 Q3 | 21.51 Billion KRW | 298.35% |
| 2016 Q2 | 5.4 Billion KRW | 254.36% |
| 2016 Q1 | -3.49 Billion KRW | 64.97% |
| 2015 Q2 | 12.18 Billion KRW | 34.44% |
| 2015 Q1 | 9.06 Billion KRW | 8.01% |
| 2015 FY | -10.15 Billion KRW | -220.96% |
| 2015 Q3 | 13.44 Billion KRW | 10.26% |
| 2015 Q4 | -9.98 Billion KRW | -174.32% |
| 2014 Q1 | 10.47 Billion KRW | -39.31% |
| 2014 Q4 | 8.39 Billion KRW | -17.36% |
| 2014 FY | 8.39 Billion KRW | -51.35% |
| 2014 Q3 | 10.15 Billion KRW | -18.44% |
| 2014 Q2 | 12.45 Billion KRW | 18.93% |
| 2013 Q2 | 26.65 Billion KRW | 10.69% |
| 2013 Q3 | 13.81 Billion KRW | -48.16% |
| 2013 Q4 | 17.25 Billion KRW | 24.89% |
| 2013 FY | 17.25 Billion KRW | 2408.58% |
| 2013 Q1 | 24.07 Billion KRW | 3321.27% |
| 2012 FY | -747.47 Million KRW | 0.0% |
| 2012 Q3 | -924.11 Million KRW | 0.0% |
| 2012 Q4 | -747.47 Million KRW | 19.11% |
| Name | Net Debt | Net Debt Difference |
|---|